Grossman E, Chang P C, Hoffman A, Tamrat M, Kopin I J, Goldstein D S
Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
Am J Physiol. 1991 May;260(5 Pt 2):R946-52. doi: 10.1152/ajpregu.1991.260.5.R946.
The rate of appearance of the sympathetic neurotransmitter norepinephrine (NE) in the regional venous drainage (NE spillover) can be estimated based on intravenous or intra-arterial infusions of [3H]NE. The present study examined whether forearm NE spillover (FASO) in humans depends on forearm blood flow (FBF) and on the site of infusion of the tracer. Healthy volunteers underwent infusions of [3H]NE and [3H]isoproterenol (Iso) administered intravenously (n = 21), intra-arterially (n = 32), or by both routes in the same experimental session (n = 7). FBF was manipulated by intra-arterial infusions of the vasodilator sodium nitroprusside (n = 7) or the vasoconstrictor methoxamine (n = 7). Forearm extraction percents of [3H]NE exceeded those of [3H]Iso in all subjects undergoing intravenous infusions (54 vs. 46%, P less than 0.001), whereas extraction percents of [3H]Iso exceeded those of [3H]NE when the tracers were infused intra-arterially. Regardless of the infusion site, FASO was positively correlated with FBF (r = 0.44, P less than 0.005). Nitroprusside increased FBF and FASO, and methoxamine decreased FBF and FASO. When the tracers were added to whole blood, 89% of [3H]NE and 83% of [3H]Iso remained in plasma after 1 min; although no further loss of [3H]NE occurred over time, only 60% of the added [3H]Iso remained in plasma by 20 min. The results indicate that regional NE spillover is flow dependent, complicating inferences about regional sympathoneural activity. Intra-arterial infusion of [3H]NE results in higher estimates of regional NE spillover than does intravenous infusion of the tracer.(ABSTRACT TRUNCATED AT 250 WORDS)
基于静脉内或动脉内输注[3H]去甲肾上腺素(NE),可估计交感神经递质去甲肾上腺素(NE)在局部静脉引流中的出现率(NE溢出)。本研究探讨了人体前臂NE溢出(FASO)是否取决于前臂血流量(FBF)以及示踪剂的输注部位。健康志愿者在同一实验时段接受静脉内输注[3H]NE和[3H]异丙肾上腺素(Iso)(n = 21)、动脉内输注(n = 32)或两种途径联合输注(n = 7)。通过动脉内输注血管扩张剂硝普钠(n = 7)或血管收缩剂甲氧明(n = 7)来控制FBF。在所有接受静脉输注的受试者中,[3H]NE的前臂提取率超过[3H]Iso(54%对46%,P小于0.001),而当示踪剂动脉内输注时,[3H]Iso的提取率超过[3H]NE。无论输注部位如何,FASO与FBF呈正相关(r = 0.44,P小于0.005)。硝普钠增加FBF和FASO,甲氧明降低FBF和FASO。当示踪剂加入全血中时,1分钟后89%的[3H]NE和83%的[3H]Iso仍留在血浆中;尽管随着时间推移[3H]NE没有进一步损失,但到20分钟时,仅60%添加的[3H]Iso仍留在血浆中。结果表明局部NE溢出取决于血流量,这使得对局部交感神经活动的推断变得复杂。与静脉内输注示踪剂相比,动脉内输注[3H]NE会导致对局部NE溢出的估计值更高。(摘要截短于250字)